KOSPI · Healthcare · ₩74B
₩3,425-0.44%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.7% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“제품 판매는 이어졌지만 이익 회복은 비용 관리에 달렸어요.”
In the company's words · 2026 2분기 filing